TE
Tectonic Therapeutic, Inc.
TECX · NASDAQ
$23.67 -4.03% (-$0.99)
1M -33.55%
Market Cap $455.1M
P/E Ratio -
Div. Yield -
ROE 35.26%
Bulios Fair Price
$18.69
21.0% downside
Current Price
$23.67
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TECX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
87 /100
Cheap P/B 2.03x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 41.75%
Asset turnover 0.00x
ROE 35.26%
Debt
69 /100
Low Debt/Equity 0.02x
Int. coverage -2,135.40x
Current ratio 22.29x
Stability
26 /100
Unstable Beta 0.22x
Profitable years 0
EPS volatility 38.30%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TECX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alise S. Reicin
Employees
60
Headquarters
Watertown
Upcoming events
05 NOV
Earnings
Upcoming earnings report